Literature DB >> 18081561

The effects of galanin-like peptide on energy balance, body temperature and brain activity in the mouse and rat are independent of the GALR2/3 receptor.

P-S Man1, C B Lawrence.   

Abstract

Galanin-like peptide (GALP) is a neuropeptide that is thought to act on the galanin receptors GALR1, GALR2 and GALR3. In rats, i.c.v. injection of GALP has dichotomous actions on energy balance, stimulating feeding over the first hour, but reducing food intake and body weight at 24 h, as well as causing an increase in core body temperature. In mice, GALP only induces an anorexic action, and its effects on core body temperature are unknown. One aim of the present study was to determine the effects of GALP on core body temperature in mice. Intracerebroventricular injection of GALP into conscious mice had no effect on feeding over 1 h, but caused a significant reduction in food intake and body weight at 24 h. It also caused an immediate drop in core body temperature, which was followed by an increase in body temperature. To understand these different effects of GALP on energy balance in mice compared to rats, and to determine the involvement of GALR2 and GALR3, immunohistochemistry was performed to localise c-Fos, a marker of cell activation. Intracerebroventricular injection of GALP induced c-Fos expression in the parenchyma surrounding the ventricles, the ventricular ependymal cells and the meninges in mice and rats. GALP also induced c-Fos expression in the supraoptic nucleus, dorsomedial hypothalamic nucleus, lateral hypothalamus and nucleus tractus solitarius in rats but not in mice. Central administration of a GALR2/3 agonist in rats did not induce c-Fos in any of the brain regions that expressed this protein after GALP injection, and had no effect on food intake, body weight and body temperature in rats or mice. These data suggest that GALP induces differential effects on energy balance and brain activity in mice compared to rats, which are unlikely to be due to activation of the GALR2 or GALR3 receptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18081561      PMCID: PMC3306895          DOI: 10.1111/j.1365-2826.2007.01625.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  34 in total

Review 1.  Galanin receptor subtypes.

Authors:  T A Branchek; K E Smith; C Gerald; M W Walker
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

2.  Distribution of galanin-1, -2 and -3 receptor messenger RNAs in central and peripheral rat tissues.

Authors:  S M Waters; J E Krause
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Effects of galanin-like peptide on food intake and the hypothalamo-pituitary-thyroid axis.

Authors:  Asha Seth; Sarah Stanley; Waljit Dhillo; Kevin Murphy; Mohammad Ghatei; Sephen Bloom
Journal:  Neuroendocrinology       Date:  2003-02       Impact factor: 4.914

4.  Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.

Authors:  S Wang; T Hashemi; S Fried; A L Clemmons; B E Hawes
Journal:  Biochemistry       Date:  1998-05-12       Impact factor: 3.162

5.  Galanin-like peptide (GALP) mRNA expression is restricted to arcuate nucleus of hypothalamus in adult male rat brain.

Authors:  J A Larm; A L Gundlach
Journal:  Neuroendocrinology       Date:  2000-08       Impact factor: 4.914

6.  Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus.

Authors:  T Ohtaki; S Kumano; Y Ishibashi; K Ogi; H Matsui; M Harada; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

7.  Distribution and regulation of galanin receptor 1 messenger RNA in the forebrain of wild type and galanin-transgenic mice.

Authors:  J G Hohmann; A Juréus; D N Teklemichael; A M Matsumoto; D K Clifton; R A Steiner
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  Analysis of the contribution of galanin receptors 1 and 2 to the central actions of galanin-like peptide.

Authors:  Stephanie M Krasnow; John G Hohmann; Alexander Gragerov; Donald K Clifton; Robert A Steiner
Journal:  Neuroendocrinology       Date:  2004-07-08       Impact factor: 4.914

9.  Differential patterns of Fos induction in the hypothalamus of the rat following central injections of galanin-like peptide and galanin.

Authors:  Gregory S Fraley; Issei Shimada; James W Baumgartner; Donald K Clifton; Robert A Steiner
Journal:  Endocrinology       Date:  2003-04       Impact factor: 4.736

10.  Intracerebroventricular galanin-like peptide induces different brain activation compared with galanin.

Authors:  Catherine B Lawrence; Torrie Williams; Simon M Luckman
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

View more
  9 in total

1.  Activation of central galanin receptor 2 mitigated insulin resistance in adipocytes of diabetic rats.

Authors:  L Guo; B He; P Fang; P Bo; Z Zhang
Journal:  J Endocrinol Invest       Date:  2020-06-25       Impact factor: 4.256

Review 2.  Galanin-like peptide (GALP) is a hypothalamic regulator of energy homeostasis and reproduction.

Authors:  Catherine Lawrence; Gregory S Fraley
Journal:  Front Neuroendocrinol       Date:  2010-06-15       Impact factor: 8.606

Review 3.  The evolving roles of alarin in physiological and disease conditions, and its future potential clinical implications.

Authors:  Endeshaw Chekol Abebe; Misganaw Asmamaw Mengstie; Mohammed Abdu Seid; Tabarak Malik; Tadesse Asmamaw Dejenie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

4.  Interleukin-1 mediates the anorexic and febrile actions of galanin-like Peptide.

Authors:  Pui-Sin Man; Catherine B Lawrence
Journal:  Endocrinology       Date:  2008-07-10       Impact factor: 4.736

5.  Altered response to metabolic challenges in mice with genetically targeted deletions of galanin-like peptide.

Authors:  Heather M Dungan Lemko; Donald K Clifton; Robert A Steiner; Gregory S Fraley
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09       Impact factor: 4.310

6.  Galanin receptors and ligands.

Authors:  Kristin E B Webling; Johan Runesson; Tamas Bartfai; Ulo Langel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-07       Impact factor: 5.555

7.  Anti-obesity effect of intranasal administration of galanin-like peptide (GALP) in obese mice.

Authors:  Haruaki Kageyama; Kanako Shiba; Satoshi Hirako; Nobuhiro Wada; Satoru Yamanaka; Yukinori Nogi; Fumiko Takenoya; Naoko Nonaka; Tsutomu Hirano; Shuji Inoue; Seiji Shioda
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

8.  Autonomic nervous system-mediated effects of galanin-like peptide on lipid metabolism in liver and adipose tissue.

Authors:  Satoshi Hirako; Nobuhiro Wada; Haruaki Kageyama; Fumiko Takenoya; Yoshihiko Izumida; Hyounju Kim; Yuzuru Iizuka; Akiyo Matsumoto; Mai Okabe; Ai Kimura; Mamiko Suzuki; Satoru Yamanaka; Seiji Shioda
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 9.  Neuropeptidergic Control of Feeding: Focus on the Galanin Family of Peptides.

Authors:  P Marcos; R Coveñas
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.